Highlights and Quick Summary
- EBIT Margin for the quarter ending December 31, 2022 was -40071.43% (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly EBIT Margin increased by 455.9%
- Annual EBIT Margin for 2022 was -24457.53% (a -50.0% decrease from previous year)
- Annual EBIT Margin for 2022 was -48915.07% (a 112.27% increase from previous year)
- Annual EBIT Margin for 2021 was -23044.07% (a -50.0% decrease from previous year)
- Twelve month EBIT Margin ending December 31, 2022 was -21134.48% (a -Infinity% decrease compared to previous quarter)
- Twelve month trailing EBIT Margin decreased by -5.35% year-over-year
Trailing EBIT Margin for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -21134.48% | 0.0% | -23805.33% | -22330.26% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Margin of Benitec Biopharma Limited
Most recent EBIT Marginof BNTC including historical data for past 10 years.Interactive Chart of EBIT Margin of Benitec Biopharma Limited
Benitec Biopharma Limited EBIT Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -40071.43% | 0.0% | 0.0% | -7208.33% | -24457.53% |
| 2021 | -19340.0% | 0.0% | -192700.0% | -379300.0% | -23044.07% |
| 2020 | -325900.0% | -4890.91% | 8036.11% | -7539.29% | -8118.63% |
| 2019 | – | – | 0.0% | -3533.33% | 21.17% |
| 2018 | – | – | – | – | -245.47% |
| 2017 | – | – | – | -319.22% | -48.83% |
| 2016 | – | – | – | 17.09% | -527.21% |
| 2015 | – | – | – | – | -262.78% |
| 2014 | – | – | – | – | -537.38% |
| 2013 | – | – | – | – | -239.62% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology